Suchergebnisse - "Janjigian, Yelena Y"

PubPharm (10)

1

Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585) : an interim analysis of the multicentre, double-blind, randomised phase 3 study

enthalten in: The Lancet. Oncology | 2024

von Shitara, K. | Rha, S. | Wyrwicz, L. | +22

2

Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Moehler, M. | Xiao, H. | Blum, S. | +21

3

Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma : interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial

enthalten in: Lancet (London, England) | 2023

von Janjigian, Y. | Kawazoe, A. | Bai, Y. | +18

CommentIn: Lancet. 2023 Dec 9;402(10418):2168-2170. - PMID 37871605

4

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

enthalten in: Nature | 2022

von Shitara, K. | Ajani, J. | Moehler, M. | +26

5

The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer

enthalten in: Nature | 2021

von Janjigian, Y. | Kawazoe, A. | Yañez, P. | +17

CommentIn: Nature. 2021 Dec;600(7890):608-609. - PMID 34912062

6

Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer : Mature Results of the CALGB 80803 (Alliance) Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Goodman, K. | Ou, F. | Hall, N. | +15

CommentIn: Strahlenther Onkol. 2022 Mar;198(3):322-324. - PMID 35015087

7

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649) : a randomised, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2021

von Janjigian, Y. | Shitara, K. | Moehler, M. | +26

CommentIn: Lancet. 2021 Jul 3;398(10294):2-3. - PMID 34102138

8

Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma : A Study of the US Gastric Cancer Consortium

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2015

von Shah, M. | Janjigian, Y. | Stoller, R. | +10

CommentIn: Nat Rev Clin Oncol. 2015 Dec;12(12):686. - PMID 26483295

9

CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2014

von Yoon, C. | Park, D. | Schmidt, B. | +6

10

A randomized controlled trial of a cardiopulmonary resuscitation video in advance care planning for progressive pancreas and hepatobiliary cancer patients

enthalten in: Journal of palliative medicine | 2013

von Epstein, A. | Volandes, A. | Chen, L. | +12

1
[1]